Side effects of drugs for osteoporosis and metastatic bone disease-Reference-Cited by-同舟云学术

Side effects of drugs for osteoporosis and metastatic bone disease

Published:2018-10-17 Issue:6 Volume:85 Page:1063-1071
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Skjødt Michael Kriegbaum¹²^ORCID,Frost Morten³⁴,Abrahamsen Bo¹⁵^ORCID

Affiliation:

1. Department of MedicineHolbæk Hospital Holbæk Denmark

2. Department of MedicineSlagelse Hospital Slagelse Denmark

3. Department of Endocrinology MOdense University Hospital Odense C Denmark

4. Steno Diabetes Centre Odense Odense C Denmark

5. Odense Patient Data Explorative NetworkInstitute of Clinical Research University of Southern Denmark and Odense University Hospital Odense C Denmark

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.13759

Reference92 articles.

1. Mortality Risk Associated With Low-Trauma Osteoporotic Fracture and Subsequent Fracture in Men and Women

2. Predictive Value of BMD for Hip and Other Fractures

3. Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With RaloxifeneResults From a 3-Year Randomized Clinical Trial

4. Comparative Effectiveness of Drug Treatments to Prevent Fragility Fractures: A Systematic Review and Network Meta-Analysis

5. Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-molecular-weight estrogenic phytoprotein suppresses osteoporosis development through positive modulation of skeletal estrogen receptors;Bioactive Materials;2024-12

2. Novel osteogenic peptide from bovine bone collagen hydrolysate: Targeted screening, molecular mechanism, and stability analysis;Food Chemistry;2024-11

3. Irilin D suppresses RANKL-induced osteoclastogenesis and prevents inflammation-induced bone loss by disrupting the NF-κB and MAPK signaling pathways;European Journal of Pharmacology;2024-11

4. Development of phytotherapeutic nanoformulation containing Gypsophila eriocalyx and its evaluation as a candidate formulation for osteoporosis treatment on human bone marrow stem cells;Phytochemical Analysis;2024-08-26

5. Betulin Stimulates Osteogenic Differentiation of Human Osteoblasts-Loaded Alginate–Gelatin Microbeads;Bioengineering;2024-05-30